Nomura Asset Management Co. Ltd. Purchases 3,410 Shares of Veeva Systems Inc. (NYSE:VEEV)

Nomura Asset Management Co. Ltd. increased its position in shares of Veeva Systems Inc. (NYSE:VEEVFree Report) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 92,364 shares of the technology company’s stock after purchasing an additional 3,410 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Veeva Systems were worth $17,782,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of VEEV. Operose Advisors LLC bought a new stake in shares of Veeva Systems during the third quarter valued at approximately $29,000. Parkside Financial Bank & Trust increased its position in shares of Veeva Systems by 81.9% during the third quarter. Parkside Financial Bank & Trust now owns 171 shares of the technology company’s stock valued at $35,000 after purchasing an additional 77 shares during the period. American National Bank bought a new stake in shares of Veeva Systems during the fourth quarter valued at approximately $36,000. Atticus Wealth Management LLC increased its position in shares of Veeva Systems by 500.0% during the third quarter. Atticus Wealth Management LLC now owns 180 shares of the technology company’s stock valued at $37,000 after purchasing an additional 150 shares during the period. Finally, Nkcfo LLC increased its position in shares of Veeva Systems by 54.7% during the third quarter. Nkcfo LLC now owns 232 shares of the technology company’s stock valued at $47,000 after purchasing an additional 82 shares during the period. 88.20% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Timothy S. Cabral sold 15,000 shares of the company’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the transaction, the director now owns 23,391 shares of the company’s stock, valued at $5,287,301.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Veeva Systems news, Director Timothy S. Cabral sold 15,000 shares of the stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $226.04, for a total value of $3,390,600.00. Following the transaction, the director now owns 23,391 shares of the company’s stock, valued at $5,287,301.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Alan Mateo sold 3,391 shares of the stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $200.86, for a total value of $681,116.26. Following the completion of the transaction, the executive vice president now directly owns 21,983 shares in the company, valued at approximately $4,415,505.38. The disclosure for this sale can be found here. Insiders have sold 21,989 shares of company stock valued at $4,818,013 over the last 90 days. 10.50% of the stock is owned by company insiders.

Veeva Systems Stock Down 0.3 %

Shares of VEEV opened at $203.89 on Monday. Veeva Systems Inc. has a 12-month low of $161.39 and a 12-month high of $236.90. The firm has a market capitalization of $32.89 billion, a PE ratio of 63.32, a price-to-earnings-growth ratio of 1.95 and a beta of 0.76. The stock’s fifty day simple moving average is $211.14 and its 200-day simple moving average is $203.35.

Veeva Systems (NYSE:VEEVGet Free Report) last issued its quarterly earnings results on Thursday, February 29th. The technology company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.11. Veeva Systems had a return on equity of 11.26% and a net margin of 22.24%. The business had revenue of $630.62 million for the quarter, compared to analyst estimates of $620.75 million. Analysts anticipate that Veeva Systems Inc. will post 4.11 EPS for the current year.

Wall Street Analysts Forecast Growth

VEEV has been the topic of a number of research reports. StockNews.com upgraded Veeva Systems from a “hold” rating to a “buy” rating in a research report on Friday, April 12th. Citigroup upped their price target on Veeva Systems from $240.00 to $264.00 and gave the company a “buy” rating in a research report on Friday, March 1st. Piper Sandler upped their price target on Veeva Systems from $220.00 to $245.00 and gave the company an “overweight” rating in a research report on Friday, March 1st. JPMorgan Chase & Co. upped their price target on Veeva Systems from $183.00 to $222.00 and gave the company a “neutral” rating in a research report on Wednesday, March 13th. Finally, Jefferies Financial Group upped their price target on Veeva Systems from $225.00 to $270.00 and gave the company a “buy” rating in a research report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus price target of $234.90.

Check Out Our Latest Analysis on VEEV

Veeva Systems Profile

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Featured Articles

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEVFree Report).

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.